AB Science S.A. - Special Call Transcript

Dec 11, 2020 / 03:00PM GMT
Operator

Ladies and gentlemen, welcome to the AB Science web conference. I will now hand over to Alain Moussy, Jean-Pierre Kinet and Olivier Hermine.

Jean Kinet, please go ahead.

Jean-Pierre Kinet - AB Science S.A. - Director

Thank you for the introduction. So welcome to the AB Science web conference where we're going to talk about masitinib in pancreatic cancer based on the recent clinical study results.

So good morning, good afternoon or good evening for all our participants from the United States and Europe. Along with me, there will be -- and Lauren can go -- Lauren is helping me with the slide show. You can go on Slide 3. So along with me, there will be 2 KOLs. Dr. Julien Taieb, Head of the Gastrology department at hospital Georges Pompidou, one of the largest hospitals in cancer in France, and specializing in pancreatic cancer. And Olivier Hermine. Professor Olivier Hermine with the President for our Scientific Committee of AB Science and is Professor of Hematology at Hospital Necker and member of the Academy of Science. And they

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot